Stockscreener 앱 받기
29.89
0.56%
0.035
전일 마감가:
$29.86
열려 있는:
$29.81
하루 거래량:
62,069
Relative Volume:
0.10
시가총액:
$1.50B
수익:
$534.53M
순이익/손실:
$-11.45M
주가수익비율:
-123.99
EPS:
-0.2411
순현금흐름:
$48.28M
1주 성능:
-0.93%
1개월 성능:
-5.57%
6개월 성능:
-14.38%
1년 성능:
-8.14%
1일 변동 폭
$29.49
$30.18
1주일 범위
$28.41
$30.38
52주 변동 폭
$28.29
$43.18
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
30.04 | 1.49B | 534.53M | -11.45M | 48.28M | -0.2411 |
|
ISRG
Intuitive Surgical Inc
|
485.17 | 175.03B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
161.87 | 46.42B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.27 | 39.37B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
235.69 | 34.98B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.37 | 34.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-18 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2026-02-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-04-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-29 | 개시 | UBS | Buy |
| 2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 재확인 | Needham | Buy |
| 2020-11-06 | 재확인 | Needham | Buy |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-24 | 재확인 | Needham | Buy |
| 2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 개시 | JP Morgan | Overweight |
| 2018-10-04 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Stifel | Buy |
| 2018-06-18 | 재확인 | Needham | Buy |
| 2018-04-27 | 재확인 | Needham | Buy |
| 2018-01-16 | 재확인 | Needham | Buy |
| 2017-11-02 | 재확인 | Needham | Buy |
| 2017-07-28 | 재확인 | Needham | Buy |
| 2017-05-30 | 재개 | Piper Jaffray | Overweight |
| 2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
| 2015-10-28 | 재확인 | Needham | Buy |
| 2015-10-06 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
AtriCure CFO Sees 12%-14% Organic Growth in 2026 as Pain Management Adoption Accelerates - Yahoo Finance
AtriCure at The Citizens Life Sciences Conference: Strategic Growth Outlook By Investing.com - Investing.com Canada
Moving Averages: Does AtriCure Inc have declining or rising EPS2026 Winners & Losers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Aug Opening: Is AtriCure Inc a cyclical or defensive stockEarnings Overview Summary & Daily Stock Trend Reports - baoquankhu1.vn
AtriCure, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Energy Moves: Is AtriCure Inc stock trending bullish2025 Fundamental Recap & Community Verified Trade Alerts - baoquankhu1.vn
Quarterly Risk: What are the analyst revisions for SMTCIs AtriCure Inc stock a good investment in YEARJuly 2025 Action & Accurate Intraday Trade Tips - baoquankhu1.vn
Merger Talk: Will AtriCure Inc stock go up in YEAR2025 Biggest Moves & Fast Gain Swing Alerts - baoquankhu1.vn
AtriCure, Inc. $ATRC Position Reduced by GW&K Investment Management LLC - MarketBeat
Aug Weekly: Why is AtriCure Inc stock going down2025 Sector Review & Safe Capital Growth Trade Ideas - baoquankhu1.vn
AtriCure (ATRC) CEO receives stock awards, uses shares to cover taxes - Stock Titan
AtriCure (ATRC) CMO granted stock awards, uses shares to cover taxes - Stock Titan
AtriCure (ATRC) CTO awarded 45,588 shares, withholds 13,127 for tax - Stock Titan
AtriCure (ATRC) CSO granted stock, transfers shares to cover taxes - Stock Titan
AtriCure (ATRC) CFO granted 63,088 shares and transfers stock for taxes - Stock Titan
AtriCure (ATRC) COO receives stock awards and surrenders shares for taxes - Stock Titan
AtriCure (ATRC) CLO receives stock awards and surrenders shares for taxes - Stock Titan
A Look At AtriCure (ATRC) Valuation After Strong 2025 Earnings And Upbeat 2026 Outlook - simplywall.st
Vanguard Group Inc. Sells 65,324 Shares of AtriCure, Inc. $ATRC - MarketBeat
AtriCure, Inc. (ATRC) Stock Analysis: Exploring a Potential 59.63% Upside as Analysts Stay Bullish - DirectorsTalk Interviews
AtriCure (NASDAQ:ATRC) Releases FY 2026 Earnings Guidance - MarketBeat
Champlain Investment Partners LLC Sells 38,541 Shares of AtriCure, Inc. $ATRC - MarketBeat
Will AtriCure’s (ATRC) 2026 Profitability Guidance Mark a Turning Point in Its Investment Narrative? - Yahoo Finance
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts - TipRanks
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 37.3% in February - MarketBeat
Reassessing AtriCure (ATRC) After Prolonged Share Price Weakness - simplywall.st
Oversold Conditions For AtriCure (ATRC) - Nasdaq
AtriCure, Inc. (ATRC) Stock Analysis: Exploring the 55.32% Potential Upside and Analysts’ Strong Buy Ratings - DirectorsTalk Interviews
AtriCure to Participate in the Citizens Life Sciences Conference - BioSpace
Aug Opening: Is XWELL Inc exposed to currency risksSell Signal & Daily Profit Focused Stock Screening - baoquankhu1.vn
Price-Driven Insight from (ATRC) for Rule-Based Strategy - Stock Traders Daily
Nasdaq Moves: Is QDEL likely to announce a buybackInflation Watch & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Will AtriCure Inc. stock go up in YEARJuly 2025 Spike Watch & Safe Capital Preservation Plans - mfd.ru
AtriCure (NASDAQ:ATRC) Upgraded at Wall Street Zen - MarketBeat
Hood River Capital Management LLC's Strategic Acquisition of Atr - GuruFocus
ETFs Investing in AtriCure, Inc. Stocks - TradingView
AtriCure (NASDAQ:ATRC) Cut to Hold at Zacks Research - MarketBeat
Decoding AtriCure Inc (ATRC): A Strategic SWOT Insight - GuruFocus
AtriCure, Inc. SEC 10-K Report - TradingView
COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal - Finviz
AtriCure Earnings Call Highlights Growth Amid Headwinds - TipRanks
Demystifying AtriCure: Insights From 6 Analyst Reviews - Benzinga
ATRC: Canaccord Genuity Lowers Price Target, Maintains Buy Ratin - GuruFocus
Needham reiterates Buy on AtriCure stock, keeps $45 target - Investing.com UK
Needham reiterates Buy on AtriCure stock, keeps $45 target By Investing.com - Investing.com Nigeria
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? - Finviz
UBS Adjusts AtriCure Price Target to $55 From $60, Maintains Buy Rating - marketscreener.com
UBS Maintains 'Buy' Rating on AtriCure (ATRC), Lowers Price Targ - GuruFocus
Citizens Jmp Cuts AtriCure (NASDAQ:ATRC) Price Target to $52.00 - MarketBeat
AtriCure (ATRC) Analyst Maintains Rating, Lowers Price Target to $52 | ATRC Stock News - GuruFocus
AtriCure Delivers 15% Revenue Growth In FY25, Projects 12-14% Growth In FY26 - Nasdaq
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
자본화:
|
볼륨(24시간):